We next evaluated the prognostic value of IP-10 for the prediction of major cardiovascular events (MACE) including death, new myocardial infarction, stroke, revascularisation (CABG or PCI) or resuscitation, in an independent cohort of 331 consecutive STEMI patients (Figure 6), as described in the methods (Table 2). The gene discussed is CXCL10; the disease is stroke disorder.